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The surgical management of rectal cancers is in a rapid
phase of evolution that will increasingly deploy minimally
invasive surgical (MIS) techniques. In this issue of Annals
of Surgical Oncology are two articles about MIS approa-
ches for rectal cancer, one comparing open versus
laparoscopic proctectomy and the other comparing lapa-
roscopic versus robotic approaches.1,2 These articles offer
an opportunity to encourage the systematic validation of
these technologies through clinical trials as they are
increasingly adopted for colorectal surgery.
Over the past decade, urologists have made great strides
in implementing robotic surgery for pelvic procedures,
although the surgical oncology and colorectal surgery
communities have not yet embraced this technology at the
same pace. For example, in 2007, approximately 50,000
radical prostatectomies were performed with the Da Vinci
robot system in the United States, or approximately 60% of
radical prostatectomies.3 In general, the reported results of
robotic prostatectomy demonstrated less blood loss and
shorter length of hospital stay; although the potency and
continence rates were comparable, a trend was noted
toward a faster return of functional outcomes.3,4 The
gynecological community has also started to use the
robotic system, which has shown similar results to those
described by urologists for prostatectomy. That is, com-
pared with open or laparoscopic techniques, robotic
surgery for radical hysterectomy resulted in less blood loss,
fewer postoperative complications, and shorter length of
stay.5–8
Last year, Mattias Soop and Heidi Nelson, in an editorial
published in Annals of Surgical Oncology, wrote, ‘‘we
believe that the cumulative literature now supports an
equipoise on short term advantages and long-term oncologic
outcomes (for laparoscopic proctectomy for cancer), making
the case for large prospective randomized trials.’’9 Since the
COST study group published its results in 2004 showing
equivalence in oncologic outcomes between open and lap-
aroscopic resection of colon cancer, the use of laparoscopic
techniques for colon cancer has become popular and has now
expanded to include rectal cancer patients.10–13 The data for
rectal cancer is still being generated, but the randomized
Conventional Versus Laparoscopic-Assisted Surgery in
Colorectal Cancer (CLASICC trial), as well as several ret-
rospective studies, demonstrate that the use of laparoscopic
techniques has at least equivalent oncologic outcomes
compared with an open laparotomy approach.12,14–16 For
example, in this issue of Annals of Surgical Oncology is a
multivariate analysis of 421 consecutive patients with stage
II and stage III rectal cancer conducted by Law and col-
leagues who retrospectively compared outcomes of open
versus laparoscopic resection.1 Laparoscopic resection was
associated with significantly less blood loss and shorter
hospital stay and was one of the independent significant
factors associated with better survival (P = .03, hazard ratio
.558, 95% confidence interval .339–.969). Ng and colleagues
from Hong Kong reported last year in Annals of Surgical
Oncology the preliminary results of a randomized trial
comparing open versus laparoscopic abdominoperineal
resection in 99 rectal cancer patients with a follow-up of
90 months.12 Their results showed that postoperative
recovery was better after laparoscopic surgery, and 5-year
survival was identical. These results are consistent with other
studies showing that laparoscopic colon resection provides
better perioperative outcomes compared with open laparot-
omy, including decreased postoperative pain, earlier return
to normal physical function, quicker return to bowel func-
tion, and shorter hospital stays.10–16
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Laparoscopic total mesorectal excision is more techni-
cally difficult, and the learning curve is steep. Conventional
laparoscopic surgery is limited in a confined surgical field
as a result of fixed instrument tips, limited dexterity of the
instruments, and a two-dimensional view. In contrast, the
Da Vinci Surgical System (Intuitive Surgical, Sunnyvale,
CA) overcomes these constraints because the instruments
provide multiple degrees of freedom, three-dimensional
imaging, ambidextrous capability, motion scaling, and
tremor elimination. It may also provide a shorter learning
curve if the start-up experience in robot-assisted radical
prostatectomy is applicable in proctectomy. Although
experienced laparoscopic surgeons may be able to over-
come some of the limitations of the use of conventional
laparoscopy in pelvis, the advantages of the robotic
instrumentation may enable a larger number of surgeons to
safely use this technology because the learning curve is less
steep and shorter. It remains to be seen whether the robot-
assisted technique may be better than the conventional
laparoscopic technique. However, it is most likely equiv-
alent to rectal surgery of average complexity, and it
provides yet another minimally invasive tool that may be
preferable in more complicated rectal surgery, such as low
rectal cancers.
In this issue, Baik and colleagues from Severance
Hospital in Seoul, Korea, report their results on 113
patients with rectal cancer who were assigned to receive
either robot-assisted low anterior resection (R-LAR,
n = 56) or laparoscopic low anterior resection (L-LAR,
n = 57).2,17 They concluded that R-LAR was performed
safely and effectively, and that perioperative outcomes
with the robotic approach were comparable to L-LAR.2
Several other centers have described their early experience
with robotic surgery in colorectal cancer and have con-
cluded that it was both feasible and safe.17–20
The technological advantage telerobotic surgery pro-
vides is the ability to perform a fine dissection in a narrow
surgical field. This theoretically translates into fewer con-
versions to an open procedure, fewer complications, and
improved oncologic outcomes. In this comparative study
by Baik and colleagues, some of these theoretical advan-
tages seem to be fulfilled. As for perioperative outcomes,
there was a significant difference in the serious complica-
tion rate and open conversion rate, both favoring the
robotic approach. The serious complication rate in the
laparoscopic group was 19.3% vs. 5.4% for the robotic
group. The open conversion rate was 10.5% in the L-LAR
group compared with 0% open conversion rate in the
robotic group. The authors make a convincing case that the
conversion to open laparotomy of most patients in the
laparoscopic group was due to the patient’s narrow pelvis,
and that this conversion might have been avoided with the
robot-assisted approach. Theoretically, autonomic nerve
preservation will also be improved, but this was not
reported in this study. There was no difference in the cir-
cumferential resection margin between the two groups.
However, the robotic group had a significantly better
macroscopic grading of the total mesorectal excision
specimen. Again, we may infer that these factors play a
role in long-term survival and local recurrence rates. Of
course, longer follow-up and larger patient populations are
needed for further evaluation.
Like many surgeons, I was initially skeptical whether
robot-assisted surgery would provide much advantage over
the conventional laparoscopic technique in complicated
rectal surgery. However, as I continue to use the robot for
low anterior resections, I have found that the system is
indeed impressive, especially when operating in the narrow
pelvis resecting a low rectal cancer. The many degrees of
freedom permitted by the instruments make the operation
easier. The visualization provided by a three-dimensional
imaging system on a fixed camera platform is better than
conventional laparoscopy. For the first time, I could per-
form a low anterior resection without suffering with low
back or neck pain. This issue cannot be underestimated, as
many surgeons who work in the pelvis routinely have
lower back problems that may shorten their career.21 In the
December 2008 issue of the American College of Sur-
geons’ Surgery News, Adrian Park reports that ‘‘nearly 9
out of 10 laparoscopic surgeons said they experienced
physical discomfort or symptoms related to performing
surgery’’ according to the results of a survey of 317 lapa-
roscopic surgeons.
This enthusiasm should not be interpreted as an unfet-
tered acceptance of this new technology, for we are
obligated to provide scientific evidence of its benefits
through prospective clinical trials. The downsides of the
robotic system are mainly cost, longer operating times, and
loss of haptic feedback compared with conventional lapa-
roscopic procedures. This is a sophisticated and expensive
technology that requires training and supervision. There is
a definite learning curve, which has been variously reported
in the urologic and gynecologic literature at 25 to 50
cases.22 With experience, the operative times will decrease.
In the Baik study, the mean operative time was virtually the
same in the two groups (190.1 ± 45.0 min in the R-LAR
group vs. 191.1 ± 65.3 min in the L-LAR group;
P = .924). Last, the robotic instruments continue to evolve,
and research is being performed to provide haptic
feedback.
The leadership of the Society of American Gastroin-
testinal and Endoscopic Surgeons (SAGES) and the
Minimally Invasive Robotic Association (MIRA) has
written a thoughtful consensus statement about the use of
robotic surgery, including recommendations for training,
credentialing, and clinical applications. They stated that
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robotic surgery can serve ‘‘as an enabling technology for
many surgeons, allowing them to provide complex mini-
mally invasive procedures to a broad range of patients. The
potential advantages of robotic surgery extend across many
different surgical subspecialties.’’23 Although this is a
sophisticated technology with proven effectiveness in some
areas of surgery, we are obligated to continue conducting
prospective clinical trials involving colorectal surgery
patients to verify that the benefits of this approach are
clearly better than that of open and laparoscopic-assisted
rectal surgery, and to learn the boundaries of patient
selection and safety with this technique. All of us who use
either robot-assisted or laparoscopic-assisted proctectomies
should participate in the ACOSOG Z6051 or a similar trial.
REFERENCES
1. Law WL, Poon JTC, Fan JKM, et al. Comparison of outcome of
open and laparoscopic resection for stage II and stage III rectal
cancer. Ann Surg Oncol. 2009. DOI: 10.1245/s10434-009-0418-4.
2. Baik SH, Kwon HY, Kim JS, et al. Robotic versus laparoscopic
low anterior resection of rectal cancer: short-term outcome of a
prospective comparative study. Ann Surg Oncol. DOI:10.1245/
s10434-009-0435-3.
3. Wexner SD, Bergamaschi R, Lacy A, et al. The current status of
robotic pelvic surgery: results of a multinational interdisciplinary
consensus conference. Surg Endosc. 2009;23:438–43.
4. Hakimi AA, Blitstein J, Feder M, et al. Direct comparison of
surgical and functional outcomes of robotic-assisted versus pure
laparoscopic radical prostatectomy: single-surgeon experience.
Urology. 2009;73:119–23.
5. Ko EM, Muto MG, Berkowitz RS, et al. Robotic versus open
radical hysterectomy: a comparative study at a single institution.
Gynecol Oncol. 2008;111:425–30.
6. Boggess JF, Gehrig PA, Cantrell L, et al. A comparative study of
3 surgical methods for hysterectomy with staging for endometrial
cancer: robotic assistance, laparoscopy, laparotomy. Am J Obstet
Gynecol. 2008;199:360.e1–360.e9.
7. Boggess JF, Gehrig PA, Cantrell L, et al. A case-control study of
robot-assisted type III radical hysterectomy with pelvic lymph
node dissection compared with open radical hysterectomy. Am J
Obstet Gynecol. 2008;199:357.e1–7.
8. Visco AG, Advincula AP. Robotic gynecologic surgery. Obstet
Gynecol. 2008;112:1369–84.
9. Soop M, Nelson H. Laparoscopic-assisted proctectomy for rectal
cancer: on trial. Ann Surg Oncol. 2008;15:2357–9.
10. Fleshman J, Sargent DJ, Green E, et al. Laparoscopic colectomy
for cancer is not inferior to open surgery based on 5-year data
from the COST Study Group trial. Ann Surg. 2007;246:655–62.
11. Aziz O, Constantinides V, Tekkis PP, et al. Laparoscopic versus
open surgery for rectal cancer: a meta-analysis. Ann Surg Oncol.
2006;13:413–24.
12. Ng SS, Leung KL, Lee JF, et al. Laparoscopic-assisted versus
open abdominoperineal resection for low rectal cancer: a pro-
spective randomized trial. Ann Surg Oncol. 2008;15:2418–25.
13. Nelson H, Sargent DJ, Wieand S, et al. A comparison of lapa-
roscopically assisted and open colectomy for colon cancer. N
Engl J Med. 2004;350:2050–9.
14. Bonjer HJ, Hop WC, Nelson H, et al. Laparoscopically assisted
vs open colectomy for colon cancer: a meta-analysis. Arch Surg.
2007;142:298–303.
15. Boller AM, Nelson H. Colon and rectal cancer: laparoscopic or
open? Clin Cancer Res. 2007;13:6894s–6s.
16. Jayne DG, Guillou PJ, Thorpe H, et al. Randomized trial of
laparoscopic-assisted resection of colorectal carcinoma: 3-year
results of the UK MRC CLASICC Trial Group. J Clin Oncol.
2007;25:3061–8.
17. Baik SH, Ko YT, Kang CM, et al. Robotic tumor-specific mes-
orectal excision of rectal cancer: short-term outcome of a pilot
randomized trial. Surg Endosc. 2008;22:1601–8.
18. Spinoglio G, Summa M, Priora F, et al. Robotic colorectal
surgery: first 50 cases experience. Dis Colon Rectum. 2008;51:
1627–32.
19. Hellan M, Anderson C, Ellenhorn JD, et al. Short-term outcomes
after robotic-assisted total mesorectal excision for rectal cancer.
Ann Surg Oncol. 2007;14:3168–73.
20. D’Annibale A, Morpurgo E, Fiscon V, et al. Robotic and lapa-
roscopic surgery for treatment of colorectal diseases. Dis Colon
Rectum. 2004;47:2162–8.
21. Berguer R, Smith W. An ergonomic comparison of robotic and
laparoscopic technique: the influence of surgeon experience and
task complexity. J Surg Res. 2006;134:87–92.
22. Lenihan JP Jr, Kovanda C, Seshadri-Kreaden U. What is the
learning curve for robotic assisted gynecologic surgery? J Minim
Invasive Gynecol. 2008;15:589–94.
23. Herron DM, Marohn M, SAGES-MIRA Robotic Surgery Con-
sensus Group. A consensus document on robotic surgery. Surg
Endosc. 2008;22:313–25.
Editorial 1453
